Clinical Cohort Construction Program of Peking University Third Hospital
1 other identifier
observational
500
1 country
1
Brief Summary
Cardiac arrest is one of the leading life-threatening emergencies, with approximately 540,000 cases occurring annually in China. Among patients who experience cardiac arrest, active cardiopulmonary resuscitation can achieve return of spontaneous circulation in 40% of cases; however, only 1-2% ultimately survive with favorable neurological outcomes. The primary contributor to mortality and morbidity is post-cardiac arrest syndrome (PCAS). PCAS represents a distinct pathophysiological process resulting from systemic ischemia/reperfusion injury, involving multiple systems and organs, and thus requires comprehensive, systematic evaluation. At present, numerous challenges remain in the field of PCAS, including the optimal targeted temperature, additional interventions that may improve neurological prognosis, post-resuscitation myocardial dysfunction and its protective strategies, characteristics and management of dysfunction in other organs, and accurate neurological prognostication after resuscitation. Therefore, in-depth research on PCAS is urgently needed to improve outcomes in cardiac arrest survivors. This study is initiated by the Department of Emergency Medicine, Peking University Third Hospital, and involves a total of six tertiary hospitals across China, constituting a multicenter investigation. The study aims to explore the effects of different targeted temperature management strategies on mortality and neurological outcomes, and to actively investigate other interventions that may ameliorate post-resuscitation brain injury, cardiac injury, and microcirculatory dysfunction, thereby reducing mortality and improving neurological prognosis in cardiac arrest patients. Furthermore, we aim to develop a neurological prediction model for cardiac arrest patients to enable accurate prognostication of neurological outcomes, which will assist emergency physicians in providing precise prognostic information to families and facilitate shared decision-making regarding subsequent treatment plans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 24, 2026
CompletedFirst Posted
Study publicly available on registry
August 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
August 13, 2026
August 1, 2026
17 years
June 24, 2026
August 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Whether death has occurred
Death: any death, regardless of cause (i.e., all-cause mortality)
1 year
Secondary Outcomes (1)
Assessment of neurological prognosis
1year
Eligibility Criteria
This study will enroll all eligible patients presenting to the emergency departments of the six centers who satisfy the following inclusion and exclusion criteria
You may qualify if:
- Patients who have achieved return of spontaneous circulation (ROSC) after cardiac arrest;
- With accessible intravenous or intraosseous vascular access;
- Clinical manifestations meeting any one of the following criteria: presenting with post-resuscitation brain injury, post-resuscitation cardiac dysfunction, manifestations of systemic ischemia-reperfusion injury, or other ongoing deteriorating pathological changes.
You may not qualify if:
- Patients who have not achieved return of spontaneous circulation (ROSC) after cardiac arrest;
- Patients who have declined cardiopulmonary resuscitation (CPR) (or whose legally authorized representative has refused CPR).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emergency Dept of Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
Related Publications (5)
Belbasis L, Bellou V. Introduction to Epidemiological Studies. Methods Mol Biol. 2018;1793:1-6. doi: 10.1007/978-1-4939-7868-7_1.
PMID: 29876887BACKGROUNDJentzer JC, Chonde MD, Dezfulian C. Myocardial Dysfunction and Shock after Cardiac Arrest. Biomed Res Int. 2015;2015:314796. doi: 10.1155/2015/314796. Epub 2015 Sep 2.
PMID: 26421284BACKGROUNDLundin A, Djarv T, Engdahl J, Hollenberg J, Nordberg P, Ravn-Fischer A, Ringh M, Rysz S, Svensson L, Herlitz J, Lundgren P. Drug therapy in cardiac arrest: a review of the literature. Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):54-75. doi: 10.1093/ehjcvp/pvv047. Epub 2015 Nov 26.
PMID: 27533062BACKGROUNDShao F, Li CS, Liang LR, Qin J, Ding N, Fu Y, Yang K, Zhang GQ, Zhao L, Zhao B, Zhu ZZ, Yang LP, Yu DM, Song ZJ, Yang QL. Incidence and outcome of adult in-hospital cardiac arrest in Beijing, China. Resuscitation. 2016 May;102:51-6. doi: 10.1016/j.resuscitation.2016.02.002. Epub 2016 Feb 23.
PMID: 26924514BACKGROUNDTrzeciak S, Jones AE, Kilgannon JH, Milcarek B, Hunter K, Shapiro NI, Hollenberg SM, Dellinger P, Parrillo JE. Significance of arterial hypotension after resuscitation from cardiac arrest. Crit Care Med. 2009 Nov;37(11):2895-903; quiz 2904. doi: 10.1097/ccm.0b013e3181b01d8c.
PMID: 19866506BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Qing bian Ma, Doctor of Medicine
Peking University Third Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Emergency Department, Peking University Third Hospital
Study Record Dates
First Submitted
June 24, 2026
First Posted
August 13, 2026
Study Start
January 1, 2014
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
August 13, 2026
Record last verified: 2026-08